| First Author | Lu J | Year | 2021 |
| Journal | J Biol Chem | Pages | 100400 |
| PubMed ID | 33571521 | Mgi Jnum | J:304847 |
| Mgi Id | MGI:6513002 | Doi | 10.1016/j.jbc.2021.100400 |
| Citation | Lu J, et al. (2021) MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway. J Biol Chem :100400 |
| abstractText | The Hippo pathway is an evolutionarily conserved signaling pathway that control organ size in animals via the regulation of cell proliferation and apoptosis. It consists of a kinase cascade, in which MST1/2 and MAP4Ks phosphorylate and activate LATS1/2, which in turn phosphorylate and inhibit YAP/TAZ activity. A variety of signals can modulate LATS1/2 kinase activity to regulate Hippo pathway. However, the full mechanistic details of kinase-mediated regulation of Hippo pathway signaling remains elusive. Here, we report that TNF activates LATS1/2 and inhibits YAP/TAZ activity through MEKK2/3. Furthermore, MEKK2/3 act in parallel to MST1/2 and MAP4Ks to regulate LATS1/2 and YAP/TAZ in response to various signals, such as serum and actin dynamics. Mechanistically, we show that MEKK2/3 interact with LATS1/2 and YAP/TAZ, and phosphorylate them. In addition, Striatin-interacting phosphatase and kinase (STRIPAK) complex associates with MEKK3 via CCM2 and CCM3 to inactivate MEKK3 kinase activity. Upstream signals of Hippo pathway trigger the dissociation of MEKK3 from STRIPAK complex to release MEKK3 activity. Our work has uncovered a previous unrecognized regulation of Hippo pathway via MEKK2/3, and provides new insights into molecular mechanisms for the interplay between Hippo-YAP and NF-kappaB signaling, and the pathogenesis of cerebral cavernous malformations. |
